ABN AMRO Group

Dividend Reinvestment Plan - ABN AMRO Group N.V.



This announcement is for information purposes only. Holders of depositary receipts (“DRs”) representing ordinary shares, with a nominal value of EUR 1.00 each in the share capital of ABN AMRO Group N.V. (the “ABN AMRO Group DRs”) ("DR holders") can participate in the dividend reinvestment plan ("DRIP") via their own custodian. ABN AMRO Bank N.V. Corporate Broking Department (“ABN AMRO CB”) only facilitates, with the approval of ABN AMRO Group N.Vmembers admitted to Euronext in Amsterdam (“Euronext Members”) and  admitted institutions of Euroclear Nederland (“Admitted Institutions”) (the Euronext Members and the Admitted Institutions are hereinafter referred as “Financial Intermediaries”), to allow their clients which are DR holders to participate in DRIP. ABN AMRO CB, in its capacity as facilitator of the DRIP, does not provide any investment services to DR holders or any other party or person and is not liable towards DR holders or any other party or person in respect of their enrolment in DRIP. If a DR holder has a question in respect of DRIP, he/she should consult its own advisor or custodian.

With reference to the press release 08 August 2018 of ABN AMRO Group N.V. (the “Company” or “ABN AMRO Group”) regarding interim dividend 2018, ABN AMRO Bank N.V. Corporate Broking Department (“ABN AMRO CB”), hereby announces that it will facilitate a dividend reinvestment plan for depositary receipts representing ordinary shares, with a nominal value of EUR 1.00 each, in the share capital of ABN AMRO Group (the ”ABN AMRO Group DRs”), held through Euroclear Nederland (the “DRIP”). The DRIP will enable holders of ABN AMRO Group DRs (“DR holders”) to reinvest their cash dividend of EUR 0.5525 net per ABN AMRO Group DR. The Company is supportive of the Plan. 

The Plan will only be available to those DR holders who (i) hold their entitlements through members admitted to Euronext in Amsterdam ("Euronext Members") or admitted Institutions of Euroclear Nederland (“Admitted Institutions”) (the Euronext Members and the Admitted Institutions are together referred to as “Financial Intermediaries” and each a “Financial Intermediary”) and (ii) expect to receive dividends for ABN AMRO Group DRs and (iii) are holders of ABN AMRO Group DRs as at the close of business on 13 August 2018 (“Record Date”).

Access to the DRIP will be provided to the DR holders through their Financial Intermediary at the request of the DR holders. DR holders must instruct their Financial Intermediary before the deadline as instructed by their Financial Intermediary. The Financial Intermediaries are required to complete the required application forms and send these application forms to ABN AMRO. Completed application forms should be received by ABN AMRO  before 3.00 p.m. CET on 27 August 2018. Application forms received after that time will not be processed. Based on the  application forms received, ABN AMRO will make purchases of existing ABN AMRO Group DRs via Euronext Amsterdam, BATS, Chi-X Europe and/or Turquoise (the ”Exchanges”). These purchases may be executed in several tranches depending on the liquidity of the ABN AMRO Group DRs on the Exchanges and the prices available at the time during the period from 28 August 2018 up to and including 29 August 2018.

In order to allocate the purchased ABN AMRO Group DRs to DR Holders, an exchange ratio will be fixed for the ABN AMRO Group DRs. Determination of the exchange ratio will be based on the daily volume weighted average price (less auction/less off exchange trades) on the Exchanges of the ABN AMRO Group DRs during the period from 28 August 2018 up to and including 29 August 2018, divided by the net dividend amount of ABN AMRO Group DRs, less fees and expenses.

To cover the fees and expenses of ABN AMRO CB in connection with the DRIP, ABN AMRO will charge an amount equal to approximately 0.375% of the net dividend amount reinvested in ABN AMRO Group DRs pursuant to the DRIP.

The exchange ratio thus determined for the ABN AMRO Group DRs will be communicated to the Financial Intermediaries on 30  August 2018. The purchased ABN AMRO Group DRs, will be delivered against payment of the reinvestment price to the Financial Intermediaries on 3 September 2018. The Financial Intermediaries will subsequently credit the DR holders' accounts against payment of the reinvestment price.

Timetable
8 August 2018: Publication HY 2018 results
10 August 2018: Ex-dividend quotation
13 August 2018, after close of business: Record date
20 August 2018: Receipt of Application Form I, only applicable if not participated in previous DRIPs
14 August 2018 – 27 August 2018 (before 15.00 CET): Period for instructions concerning dividend reinvestment  by sending under the DRIP (Receipt of Application Form II)
28 August 2018 – 29 August 2018: Period for determination of exchange ratio
30 August 2018 (before 9.00 CET): Announcement of the exchange ratio
As of 3 September 2018: Payment date and delivery date

Important information to be communicated to DR holders
Custodians of DR holders offer their clients access to the DRIP. If a DR holder wishes to make use of the DRIP, the DR holder must approach his/her Financial Intermediary that will in turn approach ABN AMRO CB. ABN AMRO CB does not have a relationship with the DR holders and only provides its services to the DR holder's Financial Intermediary. DR holders must contact their Financial Intermediary if they require any advice or more information about the DRIP.

Participating Financial Intermediaries should inform their clients that any decision by shareholders to participate in the DRIP is entirely at their discretion and shareholders may choose to opt to receive a cash dividend and to re-invest such cash dividend without requesting their bank or broker access to the DRIP or not to re-invest the cash dividend at all. Shareholders should take appropriate professional advice before making any investment decision. For the avoidance of doubt, ABN AMRO does not provide any investment services (as defined in the European Markets in Financial Instruments Directive (2014/65/EU) as implemented in the Netherlands Financial Supervision Act (Wet op het financieel toezicht) and the rules and regulations based on the foregoing) in connection with the DRIP to any party.

Participating Financial Intermediaries should furthermore inform Shareholders that their net dividend and not the gross dividend per ABN AMRO Group DR will be reinvested. The tax consequences of participating in the DRIP may vary depending on the tax residence of shareholders and class of ABN AMRO Group DRs held. Tax consequences are the sole responsibility of the DR Holder.

Participating Financial Intermediaries shall ensure that, each participating DR holder shall undertake, represent and warrant the following:

  1. the decision to make use of the DRIP is his exclusive responsibility and any acquisition of ABN AMRO Group DRs under the DRIP is at his own risk and account;
  2. it understands that ABN AMRO CB does not have any responsibility for assessing the appropriateness or suitability of its use of the DRIP or for any investment in the ABN AMRO Group DRs and that its own bank or broker is responsible for performing such suitability or appropriateness test in connection with the DRIP and for providing the  DR holder investment advice and additional information about the DRIP at its request;
  3. it acknowledges that it is not a client of ABN AMRO but of its own Financial Intermediary and that ABN AMRO shall have no obligation to provide it with any of the protections ABN AMRO affords to its own clients or to provide it with any advice in relation to the DRIP or any other matter referred to herein and that its own Financial Intermediary and not ABN AMRO must comply towards it with the conduct supervision rules pursuant to the Dutch Financial Supervision Act (Wet op het financieel toezicht) and that its own Financial Intermediary is solely responsible for any information provided to it in respect of the DRIP
  4. it understands that neither ABN AMRO nor any of its affiliates nor any of their respective directors, officers or employees has provided or will be deemed to have provided any financial, legal, regulatory, tax, accounting or investment advice in relation to the DRIP, the ABN AMRO Group DRs or otherwise;
  5. the determination of the exchange ratios will be based on volume weighted average prices for the acquisition of the ABN AMRO Group DRs on the Exchanges, which prices may be higher than the prevailing market price at the time a DRholder elects to participate in the DRIP and, accordingly, such DRholder may receive fewer ABN AMRO Group DRs than if such DRholder had at the time of election itself reinvested the cash dividends received to acquire ABN AMRO Group DRs;
  6. it is exclusively responsible, and ABN AMRO shall not be liable or responsible, for paying any taxes in connection with his participation in the DRIP;
  7. ABN AMRO does not accept any responsibility or liability in connection with a fluctuation in the price of the ABN AMRO Group DRs or for any loss or damage incurred in connection therewith;
  8. it is not prevented from participating in the DRIP by any applicable laws, rules or regulations and is participating in compliance with all applicable laws, rules and regulations;
  9. ABN AMRO may suspend or terminate the DRIP at any time, which will not affect the validity of completed transactions; and
  10. it understands that the costs under the DRIP are 0.375% and that the exchange ratio will be based on the daily volume weighted average price (less auction/less off exchange trades) on the Exchanges of the Shares during the period from 28 August 2018 up to and including 29 August 2018.

In certain jurisdictions, making use of the DRIP may be restricted by law and participating Financial Intermediary and DRholders should inform themselves about and observe any such restrictions. Any failure to comply with such restrictions may constitute a violation of the securities’ laws or regulations of any such jurisdiction. ABN AMRO does not assume any responsibility or liability for any such violation by any participating Financial Intermediary, DRholder or any other person.

Commission for the Financial Intermediaries
No commission will be paid to Financial Intermediaries in connection with the DRIP.

Instructions for the Financial Intermediaries
Application form II must be sent by email to ABN AMRO and should be received by ABN AMRO on or before 27 August 2018 15.00 CET.

Amsterdam, 08 August 2018
ABN AMRO Bank N.V. Corporate Broking Department 

Message details

Sub-group Equities
Issuer ABN AMRO Group
Category Dividend
ISIN NL0011540547
Symbol ABN
Securities name Ordinary shares
Publication date August 8 2018